← All trials
NCT06084988
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2023
- Primary completion
- Nov 8, 2024
- Completion date
- Apr 7, 2025
- First posted
- Oct 16, 2023
- Last posted
- Nov 22, 2023
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cellcolabs Clinical LTD.Lead sponsor
- PDC-CROCollaborator
- Cellcolabs Clinical LTD.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.